EssilorLuxottica Société anonyme (EL.PA)
EUR 234.5
(0.51%)
EUR 234.5
(0.51%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 6.55 Billion EUR | -16.53% |
| 2022 | 7.85 Billion EUR | -11.84% |
| 2021 | 8.91 Billion EUR | -4.41% |
| 2020 | 9.32 Billion EUR | 35.84% |
| 2019 | 6.86 Billion EUR | 167.71% |
| 2018 | 2.56 Billion EUR | 55.58% |
| 2017 | 1.64 Billion EUR | 21.09% |
| 2016 | 1.36 Billion EUR | -28.41% |
| 2015 | 1.9 Billion EUR | 25.48% |
| 2014 | 1.51 Billion EUR | 151.24% |
| 2013 | 603 Million EUR | 14.59% |
| 2012 | 526.23 Million EUR | 70.22% |
| 2011 | 309.15 Million EUR | 8.26% |
| 2010 | 285.55 Million EUR | 1.18% |
| 2009 | 282.22 Million EUR | -35.51% |
| 2008 | 437.61 Million EUR | 0.47% |
| 2007 | 435.58 Million EUR | 65.62% |
| 2006 | 262.99 Million EUR | -41.41% |
| 2005 | 448.84 Million EUR | -24.65% |
| 2004 | 595.7 Million EUR | -0.41% |
| 2003 | 598.18 Million EUR | 70.66% |
| 2002 | 350.51 Million EUR | -0.58% |
| 2001 | 352.54 Million EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 5.06 Billion EUR | 0.0% |
| 2023 Q2 | 6.56 Billion EUR | 0.0% |
| 2023 FY | 6.55 Billion EUR | -16.53% |
| 2023 Q4 | 6.55 Billion EUR | 0.0% |
| 2022 Q2 | 7.92 Billion EUR | 0.0% |
| 2022 FY | 7.85 Billion EUR | -11.84% |
| 2022 Q4 | 7.85 Billion EUR | 0.0% |
| 2021 Q2 | 8.91 Billion EUR | 0.0% |
| 2021 FY | 8.91 Billion EUR | -4.41% |
| 2021 Q4 | 8.91 Billion EUR | 0.0% |
| 2020 Q4 | 9.32 Billion EUR | 0.0% |
| 2020 FY | 9.32 Billion EUR | 35.84% |
| 2020 Q2 | 9.38 Billion EUR | 0.0% |
| 2019 FY | 6.86 Billion EUR | 167.71% |
| 2019 Q2 | 2.53 Billion EUR | 0.0% |
| 2019 Q4 | 6.86 Billion EUR | 0.0% |
| 2018 Q2 | 1.6 Billion EUR | 0.0% |
| 2018 FY | 2.56 Billion EUR | 55.58% |
| 2018 Q4 | 2.56 Billion EUR | 0.0% |
| 2017 Q4 | 1.64 Billion EUR | 0.0% |
| 2017 FY | 1.64 Billion EUR | 21.09% |
| 2017 Q2 | 1.84 Billion EUR | 0.0% |
| 2016 FY | 1.36 Billion EUR | -28.41% |
| 2016 Q2 | 1.65 Billion EUR | 0.0% |
| 2016 Q4 | 1.36 Billion EUR | 0.0% |
| 2015 FY | 1.9 Billion EUR | 25.48% |
| 2015 Q4 | 1.9 Billion EUR | 0.0% |
| 2015 Q2 | 1.58 Billion EUR | 0.0% |
| 2014 Q2 | 1.75 Billion EUR | 0.0% |
| 2014 Q4 | 1.51 Billion EUR | 0.0% |
| 2014 FY | 1.51 Billion EUR | 151.24% |
| 2013 FY | 603 Million EUR | 14.59% |
| 2013 Q4 | 607 Million EUR | 0.0% |
| 2013 Q2 | 532.3 Million EUR | 0.0% |
| 2012 FY | 526.23 Million EUR | 70.22% |
| 2012 Q2 | 538.96 Million EUR | 309.68% |
| 2012 Q1 | 131.55 Million EUR | -57.45% |
| 2012 Q4 | 526.23 Million EUR | 300.0% |
| 2012 Q3 | 131.55 Million EUR | -75.59% |
| 2011 Q2 | 282.31 Million EUR | 265.28% |
| 2011 FY | 309.15 Million EUR | 8.26% |
| 2011 Q4 | 309.15 Million EUR | 300.0% |
| 2011 Q3 | 77.28 Million EUR | -72.62% |
| 2011 Q1 | 77.28 Million EUR | -72.93% |
| 2010 FY | 285.55 Million EUR | 1.18% |
| 2010 Q3 | 71.38 Million EUR | -76.71% |
| 2010 Q1 | 71.38 Million EUR | -74.7% |
| 2010 Q4 | 285.55 Million EUR | 300.0% |
| 2010 Q2 | 306.55 Million EUR | 329.41% |
| 2009 Q3 | 70.55 Million EUR | 0.0% |
| 2009 FY | 282.22 Million EUR | -35.51% |
| 2009 Q4 | 282.22 Million EUR | 300.0% |
| 2009 Q2 | 70.55 Million EUR | 0.0% |
| 2009 Q1 | 70.55 Million EUR | -35.51% |
| 2008 Q2 | 109.4 Million EUR | 0.0% |
| 2008 Q1 | 109.4 Million EUR | 0.47% |
| 2008 FY | 437.61 Million EUR | 0.47% |
| 2008 Q3 | 109.4 Million EUR | 0.0% |
| 2008 Q4 | 109.4 Million EUR | 0.0% |
| 2007 Q2 | 108.89 Million EUR | 0.0% |
| 2007 Q1 | 108.89 Million EUR | 65.62% |
| 2007 Q4 | 108.89 Million EUR | 0.0% |
| 2007 FY | 435.58 Million EUR | 65.62% |
| 2007 Q3 | 108.89 Million EUR | 0.0% |
| 2006 Q2 | 65.74 Million EUR | 0.0% |
| 2006 Q3 | 65.74 Million EUR | 0.0% |
| 2006 Q4 | 65.74 Million EUR | 0.0% |
| 2006 Q1 | 65.74 Million EUR | -41.41% |
| 2006 FY | 262.99 Million EUR | -41.41% |
| 2005 Q1 | 112.21 Million EUR | -24.65% |
| 2005 Q2 | 112.21 Million EUR | 0.0% |
| 2005 Q3 | 112.21 Million EUR | 0.0% |
| 2005 Q4 | 112.21 Million EUR | 0.0% |
| 2005 FY | 448.84 Million EUR | -24.65% |
| 2004 FY | 595.7 Million EUR | -0.41% |
| 2004 Q4 | 148.92 Million EUR | 0.0% |
| 2004 Q3 | 148.92 Million EUR | 0.0% |
| 2004 Q2 | 148.92 Million EUR | 0.0% |
| 2004 Q1 | 148.92 Million EUR | -0.41% |
| 2003 Q3 | 149.54 Million EUR | 0.0% |
| 2003 Q1 | 149.54 Million EUR | 70.66% |
| 2003 Q2 | 149.54 Million EUR | 0.0% |
| 2003 Q4 | 149.54 Million EUR | 0.0% |
| 2003 FY | 598.18 Million EUR | 70.66% |
| 2002 FY | 350.51 Million EUR | -0.58% |
| 2002 Q1 | 87.62 Million EUR | 0.0% |
| 2002 Q2 | 87.62 Million EUR | 0.0% |
| 2002 Q4 | 87.62 Million EUR | 0.0% |
| 2002 Q3 | 87.62 Million EUR | 0.0% |
| 2001 FY | 352.54 Million EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Crossject Société Anonyme | 12.72 Million EUR | -51448.255% |
| Safe Orthopaedics SA | 5.07 Million EUR | -129141.379% |
| Spineway SA | 1.67 Million EUR | -391716.01% |
| Amplitude Surgical SA | 92.42 Million EUR | -6996.872% |
| Sartorius Stedim Biotech S.A. | 3.5 Billion EUR | -86.882% |
| bonyf N.V. | - EUR | -Infinity% |